Madrigal Pharmaceuticals Inc (MDGL.OQ)
108.91USD
25 Apr 2018
$0.10 (+0.09%)
$108.81
$107.97
$110.50
$104.31
60,319
85,781
$154.35
$13.11
Latest Key Developments (Source: Significant Developments)
Madrigal Pharmaceuticals Prices Public Offering Of Common Stock
Dec 18 (Reuters) - Madrigal Pharmaceuticals Inc
Madrigal Pharma Announces Proposed Public Offering Of Common Stock
Dec 18 (Reuters) - Madrigal Pharmaceuticals Inc
Madrigal's MGL-3196 Achieves Primary Endpoint In Patients With Biopsy-Proven Non-Alcoholic Steatohepatitis In Phase 2 Clinical Trial
Dec 6 (Reuters) - Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals reports Q3 loss per share of $0.68
Nov 9 (Reuters) - Madrigal Pharmaceuticals Inc
Rebecca Taub, M.D reports 10.38 pct stake in Madrigal Pharmaceuticals
Madrigal Pharmaceuticals Inc
Paul A. Friedman, M.D. reports 8.25 pct stake in Madrigal Pharmaceuticals
Madrigal Pharmaceuticals Inc
Bay City Capital LLC reports 49.9 pct stake in Madrigal Pharmaceuticals - SEC Filing
Madrigal Pharmaceuticals Inc
BRIEF-Madrigal Pharmaceuticals Qtrly Loss Per Share $0.67
* MADRIGAL PHARMACEUTICALS REPORTS 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS, REVIEWS KEY CORPORATE ACHIEVEMENTS AND PROVIDES CLINICAL UPDATE ON MGL-3196